Melanotan II

Tirzepatide – Advanced Dual-Agonist Metabolic Research Peptide

For Professional Research Use Only

Tirzepatide (LY3298176) is a synthetic dual-agonist research peptide designed to activate both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors.

It is widely studied for its role in metabolic regulation, glucose homeostasis, and weight-related research, and is regarded as one of the most impactful advances in incretin-based peptide science.

What Is Tirzepatide?

Tirzepatide is a modified peptide engineered to provide simultaneous GLP-1 and GIP receptor activation, offering a broader metabolic profile than single-pathway incretin compounds.

This dual-agonist design allows researchers to investigate synergistic metabolic effects related to insulin sensitivity, appetite signalling, and energy balance.

Key Research Applications

Tirzepatide is commonly studied for its potential role in:

• Weight regulation and adiposity research

• Glucose control and insulin sensitivity studies

• Type 2 diabetes research models

• Metabolic syndrome investigation

• Appetite signalling and satiety pathways

• Endocrine and incretin system research

Its dual-pathway activity makes Tirzepatide a foundational compound in modern metabolic research.

Mechanism of Action

Tirzepatide activates both GLP-1 and GIP receptors, influencing key metabolic processes such as:

• Enhanced glucose-dependent insulin secretion

• Reduced appetite signalling and increased satiety

• Improved insulin sensitivity

• Optimised nutrient utilisation

By targeting two complementary incretin pathways, Tirzepatide enables more comprehensive metabolic modulation in research environments.

Scientific & Research Insight

Clinical and laboratory research indicates that Tirzepatide:

• Produces significant reductions in body weight

• Improves glycaemic control and insulin response

• Demonstrates strong metabolic efficacy compared to GLP-1-only compounds

• Supports sustained metabolic improvements over time

These findings have established Tirzepatide as a benchmark dual-agonist peptide in metabolic research.

Product Quality & Purity

• Third-party lab tested

• ≥99% purity

• Precision-manufactured for research consistency

• Supplied in 10 mg formats

• Batch-verified for reproducibility and reliability

Each batch is produced under strict quality controls to ensure dependable research outcomes.

Important Research Disclaimer

This product is strictly for laboratory and research use only.

• Not approved for human or veterinary consumption

• Not a dietary supplement or medicine

• Intended only for controlled research environments

• Purchasers must be 18+ and comply with all applicable regulations

Storage Guidelines

• Store lyophilised powder in a freezer

• Refrigerate reconstituted solutions at 2–8°C

• Maintain sterile handling conditions for research integrity

Why Choose Us?

• Premium-grade research peptides

• Transparent purity verification

• Fast and discreet shipping

• Reliable supply for long-term research projects

Summary

Tirzepatide is a powerful dual-agonist research peptide with extensive application in metabolic, glucose, and weight-related research. Its combined GLP-1 and GIP activity, strong clinical backing, and high purity make it a critical compound for advanced metabolic studies.